Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss

AIMS: To investigate predictors of the initial response of beta‐hydroxybutyrate (BHB) and maximum BHB (max‐BHB) values during long‐term therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin (TOFO), and to explore the association of the initial elevation of BHB with subsequent clin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Obes Metab
Main Authors: Sato, Yuichi, Nunoi, Kiyohide, Kaku, Kohei, Yoshida, Akihiro, Suganami, Hideki
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973158/
https://ncbi.nlm.nih.gov/pubmed/31608549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13890
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares